CXCL5 and cancer: Since IL-23p19 plays important roles in inducing Th17 cell proliferation even in the cancer microenvironment [36,37], increased levels of CXCL5 in parallel with IL-23p19 by LL-37 could trigger angiogenesis, leading to local invasion of melanoma in the primary lesion.